QUOTED. 6 May 2019. Jeff Shuren.
The US FDA asked stakeholders to give their thoughts on a new priority list to help refine its list of patient preference-sensitive areas. See what the agency's device center chief, Jeff Shuren, said about it here.
“What we're looking at are those areas in technology where the patient perspective, their preferences, has a big impact on whether or not they would use that technology. Those are the areas then we will devote more scientific endeavors to understand those perspectives and then to incorporate it in not only our decision-making but hopefully also in product development - that's the goal." - Jeff Shuren, director, the FDA's Center for Devices and Radiological Health
- Find out more: Preferential Treatment: US FDA Asks Patients For Their Input
Click here for a free trial of Medtech Insight